Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 119
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

What Pathogens Threaten the Texas Horned Lizard?

Northern populations of the Texas Horned Lizard have experienced significant decline over recent decades. Disease...

Mapping Addiction

Addiction and drug dependence are preventable and treatable diseases. Understanding the neurophysiological...

Backer Badge Funded